At a glance
- Originator Aventis
- Class Antiepileptic drugs; Neuroprotectants; Nootropics; Small molecules
- Mechanism of Action Glutamate receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Epilepsy; Neurological disorders
Most Recent Events
- 09 Dec 1996 Discontinued-Preclinical for Neurological disorders in France (PO)
- 08 Nov 1994 Discontinued-Preclinical for Epilepsy in France (PO)